The novel antibody therapies market for advanced stage drugs is anticipated to grow at a CAGR of 36% by 2035, claims Roots Analysis
Given the potential of novel antibody therapies in the treatment of oncological disorders, there is a growing interest in evaluating such therapy candidates against other life-threatening disease indications as well
For more information, please click on the following link:
https://www.rootsanalysis.com/....reports/novel-antibo
Curtir
Comentario
Compartilhar
